Global burden of metabolic diseases, 1990–2021Huai Zhang, Omar Thaher, Xiaodong Zhou et al.|Metabolism|2024Cited by 294
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021Xiaodong Zhou, Tamer N. Abdelbaki, Qin‐Fen Chen et al.|EClinicalMedicine|2024Cited by 188
Troglitazone but not Metformin Restores Insulin-Stimulated Phosphoinositide 3-Kinase Activity and Increases p110β Protein Levels in Skeletal Muscle of Type 2 Diabetic SubjectsYoung‐Bum Kim, Barbara B. Kahn, Theodore P. Ciaraldi et al.|Diabetes|2002Cited by 129
Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver diseaseXinrong Zhang, Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong et al.|Hepatology|2022Cited by 54
Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trialXinrong Zhang, Vincent Wai‐Sun Wong, Jimmy Che‐To Lai et al.|Gut|2023Cited by 47